DOCSLIB.ORG

ARK Invest Change to the Founds Holdings

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text

Load more

IZRL - Israel Innovative Technology ETF page 1 of 8 Assets that ARK invest Sold out off No new assets detected page 2 of 8 New assets that ARK invest have added to their funds No new assets detected page 3 of 8 Assets where ARK invest decrease number of shares No new assets detected page 4 of 8 Assets where ARK invest increase number of shares Compared to 04-12-2020 Date Fund Ticker Shares bought Shares bought % Company 07-12-2020 IZRL AYLA 3.750 5,28% AYALA PHARMACEUTICALS INC 07-12-2020 IZRL SSYS 3.345 4,92% STRATASYS LTD 07-12-2020 IZRL CGEN 3.039 4,67% COMPUGEN LTD 07-12-2020 IZRL PSTI 4.752 4,47% PLURISTEM THERAPEUTICS INC 07-12-2020 IZRL RADA 7.410 4,45% RADA ELECTRONIC INDS LTD 07-12-2020 IZRL FTAL 744 4,45% FATTAL HOLDINGS 1998 LTD 07-12-2020 IZRL PERI 6.441 4,44% PERION NETWORK LTD 07-12-2020 IZRL NVMI 849 4,40% NOVA MEASURING INSTRUMENTS 07-12-2020 IZRL DANE 399 4,39% DANEL (ADIR YEOSHUA) LTD 07-12-2020 IZRL BVXV 1.218 4,39% BIONDVAX PHARMACEUTICALS-ADR 07-12-2020 IZRL INMD 1.209 4,38% INMODE LTD 07-12-2020 IZRL WIX 171 4,37% WIX.COM LTD 07-12-2020 IZRL TARO 819 4,37% TARO PHARMACEUTICAL INDUS 07-12-2020 IZRL RDHL 4.872 4,37% REDHILL BIOPHARMA LTD-SP ADR 07-12-2020 IZRL MTRX 2.025 4,36% MATRIX IT LTD 07-12-2020 IZRL CRNT 19.050 4,36% CERAGON NETWORKS LTD 07-12-2020 IZRL CYBR 435 4,36% CYBERARK SOFTWARE LTD/ISRAEL 07-12-2020 IZRL CAMT 2.664 4,35% CAMTEK LTD 07-12-2020 IZRL TEVA 5.238 4,35% TEVA PHARMACEUTICAL-SP ADR 07-12-2020 IZRL HLAN 1.116 4,35% HILAN LTD 07-12-2020 IZRL AUDC 1.458 4,34% AUDIOCODES LTD 07-12-2020 IZRL ESLT 408 4,34% ELBIT SYSTEMS LTD 07-12-2020 IZRL CHKP 381 4,34% CHECK POINT SOFTWARE TECH 07-12-2020 IZRL BEZQ 40.071 4,34% BEZEQ THE ISRAELI TELECOM CO 07-12-2020 IZRL ONE 603 4,34% ONE SOFTWARE TECHNOLOGIES LT 07-12-2020 IZRL URGN UQ 2.145 4,33% UROGEN PHARMA LTD 07-12-2020 IZRL RDWR 1.983 4,33% RADWARE LTD 07-12-2020 IZRL GMDA 9.360 4,33% GAMIDA CELL LTD 07-12-2020 IZRL ALLT 4.779 4,33% ALLOT LTD 07-12-2020 IZRL TSEM 2.457 4,32% TOWER SEMICONDUCTOR LTD 07-12-2020 IZRL GILT 9.633 4,31% GILAT SATELLITE NETWORKS LTD 07-12-2020 IZRL KMDA 6.075 4,31% KAMADA LTD 07-12-2020 IZRL SILC 1.356 4,30% SILICOM LTD 07-12-2020 IZRL PTNR 12.198 4,29% PARTNER COMMUNICATIONS CO 07-12-2020 IZRL SPNS 1.581 4,29% SAPIENS INTERNATIONAL CORP 07-12-2020 IZRL BATM 32.064 4,28% BATM ADVANCED COMMUNICATIONS 07-12-2020 IZRL NICE 204 4,27% NICE LTD - SPON ADR 07-12-2020 IZRL CEL 12.216 4,23% CELLCOM ISRAEL LTD 07-12-2020 IZRL ITRN 3.387 4,19% ITURAN LOCATION AND CONTROL 07-12-2020 IZRL FVRR 282 3,91% FIVERR INTERNATIONAL LTD 07-12-2020 IZRL PYPD 3.591 3,48% POLYPID LTD page 5 of 8 +4,3% GMDA GAMIDA CELL LTD +9.360 4,75% 225.378 shares 2.454.366,42 $ +4,3% ONE ONE SOFTWARE TECHNOLOGIES LT +603 3,65% 14.512 shares 1.885.601,60 $ +4,3% PTNR PARTNER COMMUNICATIONS CO +12.198 2,87% 296.203 shares 1.483.062,17 $ +4,2% CEL CELLCOM ISRAEL LTD +12.216 2,70% 301.206 shares 1.392.459,01 $ +4,5% RADA RADA ELECTRONIC INDS LTD +7.410 3,16% 173.796 shares 1.630.206,48 $ +4,4% FTAL FATTAL HOLDINGS 1998 LTD +744 3,05% 17.465 shares 1.575.632,16 $ +4,2% ITRN ITURAN LOCATION AND CONTROL +3.387 3,09% 84.213 shares 1.598.362,74 $ +3,9% FVRR FIVERR INTERNATIONAL LTD +282 2,91% 7.492 shares 1.502.146,00 $ +4,3% TSEM TOWER SEMICONDUCTOR LTD +2.457 3,09% 59.294 shares 1.597.973,30 $ +4,3% GILT GILAT SATELLITE NETWORKS LTD +9.633 2,86% 233.104 shares 1.475.548,32 $ +4,4% DANE DANEL (ADIR YEOSHUA) LTD +399 2,82% 9.478 shares 1.455.108,09 $ +4,4% CRNT CERAGON NETWORKS LTD +19.050 2,77% 456.420 shares 1.433.158,80 $ +4,4% TARO TARO PHARMACEUTICAL INDUS +819 2,65% 19.564 shares 1.368.697,44 $ +4,3% HLAN HILAN LTD +1.116 2,44% 26.798 shares 1.259.436,03 $ +4,3% "URGN UQ" UROGEN PHARMA LTD +2.145 1,90% 51.628 shares 980.415,72 $ +4,3% CAMT CAMTEK LTD +2.664 2,61% 63.912 shares 1.349.182,32 $ +4,4% INMD INMODE LTD +1.209 2,35% 28.822 shares 1.212.253,32 $ page 6 of 8 +4,4% NVMI NOVA MEASURING INSTRUMENTS +849 2,71% 20.140 shares 1.400.132,80 $ +4,3% NICE NICE LTD - SPON ADR +204 2,31% 4.976 shares 1.192.448,64 $ +4,3% SILC SILICOM LTD +1.356 2,58% 32.918 shares 1.333.179,00 $ +4,3% ALLT ALLOT LTD +4.779 2,26% 115.272 shares 1.168.858,08 $ +4,3% TEVA TEVA PHARMACEUTICAL-SP ADR +5.238 2,45% 125.724 shares 1.264.783,44 $ +4,4% PERI PERION NETWORK LTD +6.441 2,64% 151.391 shares 1.365.546,82 $ +3,5% PYPD POLYPID LTD +3.591 2,08% 106.651 shares 1.076.108,59 $ +4,4% MTRX MATRIX IT LTD +2.025 2,11% 48.515 shares 1.089.072,71 $ +4,3% RDWR RADWARE LTD +1.983 2,36% 47.746 shares 1.220.387,76 $ +4,3% ESLT ELBIT SYSTEMS LTD +408 2,27% 9.800 shares 1.174.314,24 $ +4,9% SSYS STRATASYS LTD +3.345 2,39% 71.400 shares 1.234.506,00 $ +4,4% WIX WIX.COM LTD +171 2,03% 4.081 shares 1.048.531,33 $ +4,3% SPNS SAPIENS INTERNATIONAL CORP +1.581 2,07% 38.447 shares 1.069.595,54 $ +4,5% PSTI PLURISTEM THERAPEUTICS INC +4.752 2,45% 111.123 shares 1.266.802,20 $ +4,4% CYBR CYBERARK SOFTWARE LTD/ISRAEL +435 2,26% 10.423 shares 1.166.125,24 $ +4,3% CHKP CHECK POINT SOFTWARE TECH +381 2,12% 9.156 shares 1.094.782,92 $ +4,3% KMDA KAMADA LTD +6.075 1,92% 147.100 shares 993.619,72 $ page 7 of 8 +4,3% BEZQ BEZEQ THE ISRAELI TELECOM CO +40.071 2,08% 964.339 shares 1.072.606,83 $ +4,3% BATM BATM ADVANCED COMMUNICATIONS +32.064 1,75% 781.877 shares 903.523,66 $ +4,3% AUDC AUDIOCODES LTD +1.458 1,92% 35.014 shares 992.296,76 $ +4,4% RDHL REDHILL BIOPHARMA LTD-SP ADR +4.872 1,95% 116.456 shares 1.008.508,96 $ +4,7% CGEN COMPUGEN LTD +3.039 1,66% 68.058 shares 857.530,80 $ +5,3% AYLA AYALA PHARMACEUTICALS INC +3.750 1,59% 74.730 shares 822.030,00 $ +4,4% BVXV BIONDVAX PHARMACEUTICALS-ADR +1.218 0,23% 28.980 shares 120.556,80 $ +0,0% MORGAN STANLEY GOVT INSTL 8035 +0 0,12% 61.758 shares 61.757,70 $ page 8 of 8.
Recommended publications
  • Semiconductor Sector Report

    Semiconductor Sector Report

    SEMICONDUCTOR SECTOR REPORT SAVVIAN, LLC 150 CALIFORNIA STREET, SAN FRANCISCO, CA 94111 | www.savvian.com | 415.318.3600 MARKET HIGHLIGHTS Inside this issue MARKETMARKET HIGHLIGHTSHIGHLIGHTS STMicroelectronics (NYSE:STM, Paris: STM.PA, Milan:STM.MI), Intel (NASDAQ:INTC) and Francisco Partners entered into a definitive agreement to create a new independent semiconductor company from the key assets of businesses which Market Highlights last year generated approximately $3.6Bn in combined annual revenue. The new company’s strategic focus will be on Summary Performance supplying flash memory solutions for a variety of consumer and industrial devices. Two Global Positioning Systems (GPS) related private companies were acquired, confirming the emerging significance of Observations GPS-related technology in the semiconductor industry. In early June, Broadcom (NASDAQ: BRCM) signed a definitive Trading Data agreement to acquire Global Locate, Inc for $226MM. In late June, GPS chipmaker SiRF Technology Holdings Inc. (NASDAQ: SIRF) announced the purchase of Centrality Communications for $283MM. Transaction Activity Early in the quarter, Linear Technology announced a $3Bn Accelerated Stock Repurchase in combination with $1.7Bn in Savvian Update privately placed convertible senior notes. This financing was noticed and emulated by numerous other large capitalization companies who are seeking to optimize their capital structures in light of increased shareholder pressure and private equity interest. Applied Materials (NASDAQ:AMAT) acquired HCT Shaping Systems, a Swiss solar company, for CHF 583MM ($475MM) in cash, extending the company’s reach in the solar industry. The acquisition advances AMAT’s strategy leveraging its semiconductor process capability into complementary adjacent markets. Zarlink (NYSE / TSX: ZL) signed a definitive agreement to acquire privately held Legerity Holdings for $135MM in cash.
  • The Advisory Committee for the FTSE Med-100 Index, Had Its Semi-Annual Meeting Today, 14Th of November 2012

    The Advisory Committee for the FTSE Med-100 Index, Had Its Semi-Annual Meeting Today, 14Th of November 2012

    The Advisory Committee for the FTSE Med-100 Index, had its semi-annual meeting today, 14th of November 2012. The FTSE Med-100 Index which was launched on the 19/6/2003 is composed of 100 stocks of three Exchanges (Athens Exchange, Tel-Aviv Stock Exchange and Cyprus Stock Exchange). The Advisory Committee of the index is comprised of representatives from the three Exchanges and also from the global index provider “FTSE Group”. During this meeting, the committee reviewed the operation of the index for the six months period between May 2012 – October 2012, in accordance with its ground rules, which follow international standards. Having applied the index rules, no changes are applicable in the constituent list of the index. The index is composed of 65 stocks listed on the Tel-Aviv Stock Exchange, 22 stocks listed on the Athens Exchange and 13 stocks listed on the Cyprus Stock Exchange. The list of the constituent 100 companies is as follows: Country Capital value (Euro million) 1 Teva Pharmaceutical Israel 27.292,7 2 Israel Chemicals Israel 12.219,9 3 Coca-Cola HBC Greece 6.031,4 4 Israel Corporation Israel 4.035,7 5 Bank Hapoalim Israel 3.986,6 6 Bank Leumi Israel 3.646,5 7 Bezeq Israel 2.556,6 8 Azrieli Group Israel 2.097,3 9 Mellanox Technologies Israel 1.947,6 10 Hellenic Petroleum (Cr) Greece 1.845,0 11 Natl Bank Of Greece Greece 1.710,1 12 Hellenic Telecom Greece 1.670,3 13 Delek Group Israel 1.668,5 14 Nice Systems Israel 1.603,7 15 Mizrahi Tefahot Bank Ltd.
  • Market Cap Close ADV 1598 67Th Pctl 745,214,477.91 $ 23.96

    Market Cap Close ADV 1598 67Th Pctl 745,214,477.91 $ 23.96

    Market Cap Close ADV 1598 67th Pctl $ 745,214,477.91 $ 23.96 225,966.94 801 33rd Pctl $ 199,581,478.89 $ 10.09 53,054.83 2399 Ticker_ Listing_ Effective_ Revised Symbol Security_Name Exchange Date Mkt Cap Close ADV Stratum Stratum AAC AAC Holdings, Inc. N 20160906 M M M M-M-M M-M-M AAMC Altisource Asset Management Corp A 20160906 L M L L-M-L L-M-L AAN Aarons Inc N 20160906 H H H H-H-H H-H-H AAV Advantage Oil & Gas Ltd N 20160906 H L M H-L-M H-M-M AB Alliance Bernstein Holding L P N 20160906 H M M H-M-M H-M-M ABG Asbury Automotive Group Inc N 20160906 H H H H-H-H H-H-H ABM ABM Industries Inc. N 20160906 H H H H-H-H H-H-H AC Associated Capital Group, Inc. N 20160906 H H L H-H-L H-H-L ACCO ACCO Brand Corp. N 20160906 H L H H-L-H H-L-H ACU Acme United A 20160906 L M L L-M-L L-M-L ACY AeroCentury Corp A 20160906 L L L L-L-L L-L-L ADK Adcare Health System A 20160906 L L L L-L-L L-L-L ADPT Adeptus Health Inc. N 20160906 M H H M-H-H M-H-H AE Adams Res Energy Inc A 20160906 L H L L-H-L L-H-L AEL American Equity Inv Life Hldg Co N 20160906 H M H H-M-H H-M-H AF Astoria Financial Corporation N 20160906 H M H H-M-H H-M-H AGM Fed Agricul Mtg Clc Non Voting N 20160906 M H M M-H-M M-H-M AGM A Fed Agricultural Mtg Cla Voting N 20160906 L H L L-H-L L-H-L AGRO Adecoagro S A N 20160906 H L H H-L-H H-L-H AGX Argan Inc N 20160906 M H M M-H-M M-H-M AHC A H Belo Corp N 20160906 L L L L-L-L L-L-L AHL ASPEN Insurance Holding Limited N 20160906 H H H H-H-H H-H-H AHS AMN Healthcare Services Inc.
  • Advancing Cell Therapeutic Products for Clinical Use

    Advancing Cell Therapeutic Products for Clinical Use

    Advancing cell therapeutic products for clinical use 1 Proprietary data of Pluristem Therapeutics Inc. Forward Looking Statement This presentation concerning Pluristem Therapeutics may include forward- looking statements which represent Pluristem Therapeutics' expectations or beliefs regarding future events. I caution that such statements involve risks and uncertainties that may cause actual results to differ materially from those in the forward-looking statements. Consequently, all such forward-looking statements are qualified by the cautionary language and risk factors set forth in Pluristem Therapeutics' periodic and other reports filed with the SEC. There can be no assurance that the actual results, events or developments referenced in such forward-looking statements will occur or be realized. Pluristem Therapeutics assumes no obligation to update these forward- looking statements to reflect actual results, changes in assumptions or changes in factors affecting such forward-looking statements. www.pluristem.com 2 Proprietary data of Pluristem Therapeutics Inc. Corporate Overview • Cell therapy company (NasdaqCM: PSTI, TASE: PSTI) • Using off-the-shelf, placenta-derived cells to achieve both local and systemic therapeutic effects – no tissue matching needed • First-in-class 3D cell culturing technology allowing for efficient, controlled production of multiple cell products in commercial quantities – “the process is the product” • Active with regulators in the U.S., EU, S. Korea, Australia & Israel • Demonstrated safety and efficacy in 3 clinical studies (two Phase I and one Phase I/II study) 3 Proprietary data of Pluristem Therapeutics Inc. Financial Overview • Market Cap: ~ $200 million • Cash and marketable securities: $41 million (March, 2015) • No debt • Net burn: ~ $23 million • 165 employees (16 PhD, 4 MD) • IP Ownership: over 40 granted patents and ~150 pending applications 4 Proprietary data of Pluristem Therapeutics Inc.
  • TOWER SEMICONDUCTOR LTD. (Translation of Registrant's Name Into English)

    TOWER SEMICONDUCTOR LTD. (Translation of Registrant's Name Into English)

    FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 For the month January 2021 No. 1 TOWER SEMICONDUCTOR LTD. (Translation of registrant's name into English) Ramat Gavriel Industrial Park P.O. Box 619, Migdal Haemek, Israel 2310502 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F. Form 20-F ☒ Form 40-F ☐ Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934. Yes ☐ No ☒ On January 5, 2021, the Registrant Announce Program Creating an Integrated-Laser-on-Silicon Photonics Foundry Process SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. TOWER SEMICONDUCTOR LTD. Date: January 5, 2021 By: /s/ Nati Somekh Name: Nati Somekh Title: Corporate Secretary NEWS ANNOUNCEMENT FOR IMMEDIATE RELEASE Tower Semiconductor Announces Program Creating an Integrated-Laser-on-Silicon Photonics Foundry Process Advanced process to be developed with partial funding from the DARPA LUMOS program addressing high-speed communications MIGDAL HAEMEK, Israel, January 05, 2021 – Tower Semiconductor (NASDAQ/TASE: TSEM), the leader in high-value analog semiconductor foundry solutions, today announced that it is participating in the LUMOS program, with partial support from DARPA, to create a semiconductor foundry integrated-laser-on-silicon photonics process. This process will combine high performance III-V laser diodes with Tower’s PH18 production silicon photonics platform.
  • White Phosphorus (WP) and Smoke Mortars in 60Mm, 81Mm and 120Mm Calibers, Equipped with Point Detonating, Proximity and Electronic Time Fuses

    White Phosphorus (WP) and Smoke Mortars in 60Mm, 81Mm and 120Mm Calibers, Equipped with Point Detonating, Proximity and Electronic Time Fuses

    UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 20-F ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 for the fiscal year ended December 31, 2010 Commission File No. 0-28998 ELBIT SYSTEMS LTD. (Exact name of registrant as specified in its charter and translation of registrant’s name into English) Israel (Jurisdiction of incorporation or organization) Advanced Technology Center, Haifa 31053, Israel (Address of principal executive offices) Joseph Gaspar c/o Elbit Systems Ltd. P.O. Box 539 Advanced Technology Center Haifa 31053 Israel Tel: 972-4-831-6404 Fax: 972-4-831-6944 E-mail: [email protected] (Name, telephone, e-mail and/or facsimile number and address of Company contact person) Securities registered or to be registered pursuant to Section 12(b) of the Act: Ordinary Shares, nominal value 1.0 New Israeli Shekels per share (Title of Class) The NASDAQ Global Select Market (Name of each Exchange on which registered) Securities registered or to be registered pursuant to Section 12(g) of the Act: Not Applicable Securities for which there is a reporting obligation pursuant to Section 15(d) of the Act: Not Applicable Indicate the number of outstanding shares of each of the issuer’s classes of capital or common stock as of the close of the period covered by the annual report: 42,693,340 Ordinary Shares Indicate by check mark whether the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes x No o If this report is an annual or transition report, indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.
  • TOWER SEMICONDUCTOR LTD. (Translation of Registrant's Name Into English)

    TOWER SEMICONDUCTOR LTD. (Translation of Registrant's Name Into English)

    FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 For the month May 2018 No. 3 TOWER SEMICONDUCTOR LTD. (Translation of registrant's name into English) Ramat Gavriel Industrial Park P.O. Box 619, Migdal Haemek, Israel 2310502 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F. Form 20-F ☒ Form 40-F ☐ Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934. Yes ☐ No ☒ On May 9, 2018, the Registrant and Newsight Imaging Announce Advanced CMOS Image Sensor Chips for LiDAR used in ADAS and Autonomous Vehicles SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. TOWER SEMICONDUCTOR LTD. Date: May 9, 2018 By: /s/ Nati Somekh Name: Nati Somekh Title: Corporate Secretary NEWS ANNOUNCEMENT FOR IMMEDIATE RELEASE TowerJazz and Newsight Imaging Announce Advanced CMOS Image Sensor Chips for LiDAR used in ADAS and Autonomous Vehicles Customized for high volume markets of automotive visual safety solutions as well as drones and autonomous home appliance robots MIGDAL HAEMEK and NESS ZIONA, Israel, May 9, 2018 – TowerJazz, the global specialty foundry leader, and Newsight Imaging, today announced production of Newsight’s advanced CMOS image sensor (CIS) chips and camera modules, customized for very high volume LiDAR and machine vision markets, combining sensors, digital algorithms and pixel array on the same chip.
  • NASDAQ Stock Market

    NASDAQ Stock Market

    Nasdaq Stock Market Friday, December 28, 2018 Name Symbol Close 1st Constitution Bancorp FCCY 19.75 1st Source SRCE 40.25 2U TWOU 48.31 21st Century Fox Cl A FOXA 47.97 21st Century Fox Cl B FOX 47.62 21Vianet Group ADR VNET 8.63 51job ADR JOBS 61.7 111 ADR YI 6.05 360 Finance ADR QFIN 15.74 1347 Property Insurance Holdings PIH 4.05 1-800-FLOWERS.COM Cl A FLWS 11.92 AAON AAON 34.85 Abiomed ABMD 318.17 Acacia Communications ACIA 37.69 Acacia Research - Acacia ACTG 3 Technologies Acadia Healthcare ACHC 25.56 ACADIA Pharmaceuticals ACAD 15.65 Acceleron Pharma XLRN 44.13 Access National ANCX 21.31 Accuray ARAY 3.45 AcelRx Pharmaceuticals ACRX 2.34 Aceto ACET 0.82 Achaogen AKAO 1.31 Achillion Pharmaceuticals ACHN 1.48 AC Immune ACIU 9.78 ACI Worldwide ACIW 27.25 Aclaris Therapeutics ACRS 7.31 ACM Research Cl A ACMR 10.47 Acorda Therapeutics ACOR 14.98 Activision Blizzard ATVI 46.8 Adamas Pharmaceuticals ADMS 8.45 Adaptimmune Therapeutics ADR ADAP 5.15 Addus HomeCare ADUS 67.27 ADDvantage Technologies Group AEY 1.43 Adobe ADBE 223.13 Adtran ADTN 10.82 Aduro Biotech ADRO 2.65 Advanced Emissions Solutions ADES 10.07 Advanced Energy Industries AEIS 42.71 Advanced Micro Devices AMD 17.82 Advaxis ADXS 0.19 Adverum Biotechnologies ADVM 3.2 Aegion AEGN 16.24 Aeglea BioTherapeutics AGLE 7.67 Aemetis AMTX 0.57 Aerie Pharmaceuticals AERI 35.52 AeroVironment AVAV 67.57 Aevi Genomic Medicine GNMX 0.67 Affimed AFMD 3.11 Agile Therapeutics AGRX 0.61 Agilysys AGYS 14.59 Agios Pharmaceuticals AGIO 45.3 AGNC Investment AGNC 17.73 AgroFresh Solutions AGFS 3.85
  • Israel and the Alien Tort Statute

    Israel and the Alien Tort Statute

    Summer 2014 No.54 JTheUSTICE magazine of the International Association of Jewish Lawyers and Jurists In this issue The International Court of Justice Adjudicating the Arab-Israel Disputes? Boycotts, Divestment, Sanctions and the Law Israel and the Alien Tort Statute Corporations and Human Rights Zivotofsky v. Kerry - A Historical Constitutional Battle Preachers of Hate and Freedom of Expression UNRWA Panel at UN IAJLJ Activities The International Association of Jewish Lawyers and Jurists Honorary President: Hadassa Ben-Itto, Judge (Ret.) (Israel) Life time Member: Irwin Cotler, Prof. (Canada) Honorary Vice Presidents: Joseph Roubache (France) Oreste Bisazza Terracini, Dr. (Italy) Executive Committee: Board of Governors: President: Irit Kohn (Israel) Irit Kohn (Israel) Haim Klugman (Israel) Avraham (Avi) D. Doron (Israel) Deputy President: Meir Rosenne, Dr. (Israel) Haim Klugman (Israel) Mirella M. Bamberger (Israel) Alyza D. Lewin (USA) Vice President and Treasurer: Marcos Arnoldo Grabivker, Judge (Argentina) Avraham (Avi) D. Doron (Israel) Maurizio Ruben (Italy) Alex Hertman (Israel) Vice President and Coordinator with Amos Shapira, Prof. (Israel) International Organizations: Avishai Sapir (Israel) Meir Rosenne, Dr. (Israel) David Pardes (Belgium) Dov Shefi, Brig. (Ret.) (Israel) Vice President and Secretary General: Edna Bekenstein, Judge (Ret.) (Israel) Mirella M. Bamberger (Israel) Edna Kaplan-Hagler, Judge (Ret.) Dr. (Israel) Efraim (Efi) Chalamish, Dr. (USA) Vice Presidents: Ethia Simha (Israel) Alyza D. Lewin (USA) Jeremy D. Margolis (USA) Marcos Arnoldo Grabivker, Judge (Argentina) Jimena Bronfman (Chile) Maurizio Ruben (Italy) Jonathan Lux (UK) Lipa Meir, Dr. (Israel) Academic Adviser: Mala Tabory, Dr. (Israel) Yaffa Zilbershats, Prof. (Israel) Maria Canals De-Cediel, Dr. (Switzerland) Meir Linzen (Israel) Representatives to the U.N.
  • Biolinerx Ltd. (Translation of Registrant’S Name Into English) ______

    Biolinerx Ltd. (Translation of Registrant’S Name Into English) ______

    SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of February 2018 _______________________ BioLineRx Ltd. (Translation of registrant’s name into English) _______________________ 2 HaMa’ayan Street Modi’in 7177871, Israel (Address of Principal Executive Offices) _______________________ Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F: Form 20-F ☑ Form 40-F ☐ Indicate by check mark whether the registrant by furnishing the information contained in this form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934: Yes ☐ No ☑ The registrant hereby announces that it has entered into an employment agreement with Hillit Mannor Shachar, M.D., MBA, M.S.F.S., to serve as its new Vice President Business Development, effective April 1, 2018. Dr. Shachar will be responsible for BioLineRx’s business development, commercialization of assets and pipeline strategy. Dr. Shachar joins BioLineRx with over 15 years of experience in senior business development, corporate development and venture capital positions in the life sciences field. Her recent experience has included service as Vice President Business Development of Pluristem Therapeutics (NASDAQ:PSTI), a leading developer of placenta-based cell therapy products, and Director of New Business Development at West Pharmacuetical Services. In addition, Dr. Shachar has served at several life science companies and venture capital funds, including Apax Partners, Nektar Therapeutics, Orex Computed Radiography, Kodak and Transpharma Medical.
  • PLURISTEM THERAPEUTICS INC. (Exact Name of Registrant As Specified in Its Charter)

    PLURISTEM THERAPEUTICS INC. (Exact Name of Registrant As Specified in Its Charter)

    UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended June 30, 2018 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from [ ] to [ ] Commission file number 001-31392 PLURISTEM THERAPEUTICS INC. (Exact name of registrant as specified in its charter) Nevada 98-0351734 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.) MATAM Advanced Technology Park, Building No. 5, Haifa, Israel 31905 (Address of principal executive offices) (Zip Code) Registrant's telephone number 011-972-74-7107259 Securities registered pursuant to Section 12(b) of the Act: Title of each class Name of each exchange on which registered Common Stock, par value $0.00001 Nasdaq Capital Market Securities registered pursuant to Section 12(g) of the Act: None. (Title of class) Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes ☐ No ☒ Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes ☐ No ☒ Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
  • Life Sciences in Israel

    Life Sciences in Israel

    STATE OF ISRAEL Ministry of Industry Trade and Labor Investment Promotion Center Inspiration Invention Innovation Life Sciences in Israel www.investinisrael.gov.il Table of Contents .......................................... 3 Israel: A Powerhouse of Opportunities ............................................................ 3 Israel’s Life Science Sectors Medical Devices ........................................................................ 4 Healthcare IT ............................................................................ 4 BioPharmaceutical .................................................................... 7 Israel’s Biomedical Engineering - ................................................... 11 Spotlight on Stem Cell Research ....................................... 15 Israel’s Life Sciences Competitive Edge ..................................................................... 19 Government Support 2 Life Sciences in Israel Israel: A Powerhouse of Opportunities Why Israel’s Life Sciences Over the last decade, Israel has introduced a wealth of groundbreaking More than 1,000 Life and valuable innovations in Life Sciences. Israel’s Life Sciences sector Sciences Companies - is supported by a strong foundation of academic excellence, including Biopharma and Medical some of the world’s leading research institutes, renowned R&D Devices facilities and cutting-edge medical centers. Bolstered by a highly skilled Over 1/3 of LS Start-Ups workforce, a flourishing high-tech environment, and an entrepreneurial already generate revenue